ARTICLE | Company News
Neoprobe licenses new ACT patent
July 28, 2000 7:00 AM UTC
The Ohio State University Research Foundation received U.S. Patent No. 6,093,381 covering the ability of activated cellular therapy (ACT) to enhance the effectiveness of chemotherapy drugs in attackin...